Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis

Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis

Background and objective: Best-value biological medicines may generate competition in the off-patent biologicals market, resulting in having more resources available to provide patients with access to necessary medicines while maintaining high-quality care. Belgium is a country known to have low bio...

Full description

Bibliographic Details
Main Authors: Yannick Vandenplas, Steven Simoens, Philippe Van Wilder, Arnold G. Vulto, Isabelle Huys
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Pharmacology
Subjects:
biological
medicine
competition
sustainability
market access
affordability
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.644187/full

Similar Items

Similar Items